EUVIMEDEUVIMED entdecken
Crossref

Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period

Takashi Sakoh, Emiko Miyajima, Yusuke Endo, Masaru Baba, Mizuki Haraguchi, Masayo Morishima, Sho Ogura, Muneyoshi Kimura, Hideki Araoka

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04960-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Takashi Sakoh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cefiderocol, Cephalosporins, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Okinaka Memorial Institute for Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCefiderocolCephalosporinsGram-Negative Bacterial InfectionsHospitalsStenotrophomonas maltophiliaHumansBacteremiaJapanMicrobial Sensitivity TestsRetrospective Studies

Stichwörter der Autor:innen

Stenotrophomonas maltophiliaBloodstream infectionCefiderocolDrug susceptibilityJapan

Substanzen

Anti-Bacterial AgentsCefiderocolCephalosporins

Autor:innen und Institutionen

  • Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
  • Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. h-araoka@toranomon.gr.jp.
  • Okinaka Memorial Institute for Medical Research, Tokyo, Japan. h-araoka@toranomon.gr.jp.

Förderung

  • Okinaka Memorial Institute for Medical Research

Zitieren

APA

Sakoh, T., Miyajima, E., Endo, Y., Baba, M., Haraguchi, M., Morishima, M., Ogura, S., Kimura, M., & Araoka, H. (2024). Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04960-2

Vancouver

Sakoh T, Miyajima E, Endo Y, Baba M, Haraguchi M, Morishima M, et al. Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04960-2

BibTeX
@article{Sakoh2024,
  author = {Sakoh, Takashi and Miyajima, Emiko and Endo, Yusuke and Baba, Masaru and Haraguchi, Mizuki and Morishima, Masayo and Ogura, Sho and Kimura, Muneyoshi and Araoka, Hideki},
  title = {Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04960-2}
}
Kostenlos starten →